← Evidence map

ReviewJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2020

Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions.

Mikhail Melnikov et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31011885